Skin Graft Market is expected to reach US$ 1,673.5 million by 2028

PRESS RELEASE BY The Insight Partners 30 Apr 2021

Share this press on

Autologous Segment to Register Highest CAGR During 2021–2028


According to our new research study on “Skin Graft Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Graft Thickness,  Applications, Equipment, and End Users,” the market is expected to reach US$ 1,673.5 million by 2028 from US$ 985.4 million in 2020. It is estimated to grow at a CAGR of 7.0% from 2021 to 2028. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as the increasing numbers of burn injuries and rising prevalence of skin cancer and diabetes fuel the growth of the market. However, the high cost of skin grafting procedures and alternatives hinders the market growth.


In 2020, the autologous segment accounted for the largest share of the global skin graft market. The market growth for this segment can be attributed to the wide use of autologous grafts for treating open burns and wounds. These grafts are available by prescription only, and their use is highly regulated. Therefore, the market for autologous grafts segment is expected to grow steadily during the forecast period.


B. Braun Melsungen AG, Integra Life Sciences Corporation, Smith & Nephew, AVITA Medical, MiMedx, Organogenesis Inc, Tissue Regenix Group, Zimmer Biomet, De Soutter Medical, and Nouvag AG are among the leading companies operating in the skin graft market. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the skin graft. For instance, in September 2020, MiMedx Group, Inc. launched EpiCord Expandable, a latest advancement in its products portfolio. At the core of this technology is EpiCord, which has demonstrated clinical efficacy in the treatment of diabetic foot ulcers.

Skin Graft Market, by Region, 2020 (%)

Skin Graft Market, by Region, 2020 (%)

Skin Graft Market to Grow at a CAGR of 7.0% to reach US$ 1,673.5 million from 2021 to 2028

Download Free Sample

Skin Graft Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Autologous, Allogeneic, Xenogeneic, Prosthetic, and Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, and Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, and Other Applications), Equipment (Dermatome, General Surgical Instruments, Consumables, and Others), and End User (Ambulatory Surgical Centers, Hospitals, and Dermatology Clinics) and Geography


The report segments global Skin Graft market as follows:


By Product

  • Autologous
  • Allogeneic
  • Xenogeneic
  • Prosthetic
  • Isogeneic


By Graft Thickness

  • Split-Thickness
  • Full-Thickness
  • Composite Graft


By Equipment

  • Dermatome
  • General Surgical Instruments
  • Consumables
  • Others


By Application

  • Burns
  • Extensive Wound
  • Skin Cancer
  • Other Applications


By End Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Dermatology Clinics


By Geography

  • North America
      • US
      • Canada
      • Mexico
  • Europe
      • France
      • Germany
      • UK
      • Spain
      • Italy
      • Rest of Europe
  • Asia Pacific (APAC)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of APAC
  • Middle East & Africa (MEA)
      • Saudi Arabia
      • UAE
      • South Africa
      • Rest of MEA
  • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

Contact Us
Phone: +1-646-491-9876
Email Id:

Download Free PDF Brochure